Showing 2011-2020 of 3133 results for "".
Marathon Dermatology
https://practicaldermatology.com/topics/general-topics/marathon-dermatology/20997/As the popularity of running continues to grow, dermatologists need rapid ready responses to address acute presenting problems, as well as counseling measures to help prevent recurrence.Electronic Brachytherapy: Understanding the Technology and Identifying Appropriate Use
https://practicaldermatology.com/topics/practice-management/electronic-brachytherapy-understanding-the-technology-and-identifying-appropriate-use/21148/The following information is for dermatology practices concerning Appropriate Use Criteria (AUC) for Electronic Brachytherapy.Non-invasive “Mega” Laser Combinations: How to Achieve Maximal Results
https://practicaldermatology.com/topics/practice-management/non-invasive-mega-laser-combinations-how-to-achieve-maximal-results/21150/Improved outcomes and shortened downtime are just some of the advantages of multi-modality approaches to the evolving non-invasive aesthetic front.ICD-10: Facts, Myths, and Solutions
https://practicaldermatology.com/topics/practice-management/facts-mythsand-solutions/21422/With the deadline for implementation of the new Medicare coding system just months away, physicians need to prepare their practices for a significant transition.Integrating Excimer Laser Therapy for Psoriasis and Vitiligo
https://practicaldermatology.com/topics/psoriasis/integrating-excimer-laser-therapy-for-psoriasis-and-vitiligo/22959/New patient and practice support programs may expand interest in laser therapy for common medical conditions.Physician Programs: Opening new Patient Gateways
https://practicaldermatology.com/topics/practice-management/physician-programs-opening-new-patient-gateways/22914/Physician programs support dermatologists' practice building and provide a gateway for additional services.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21836/First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Redefining the Discourse: Psoriasis in Diverse Skin Tones
https://practicaldermatology.com/topics/psoriasis/redefining-the-discourse-psoriasis-in-diverse-skin-tones/23856/A lack of representation for underserved ethno-racial groups in clinical data and research is an underlying factor contributing to physicians’ challenges with effectively diagnosing and treating psoriasis in patients with diverse skin tones.Currents: PsO Many Options
https://practicaldermatology.com/topics/psoriasis/currents-pso-many-options/23211/